Evidence item

The passage directly supports delayed rebound and the 45.4 versus 4.6 week ART-restart comparison, but it does not address intact-provirus decline. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 16963

Source: Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial · locator {} · excerpt hash sha256:e000fabcedd717fdaabed01adaf38aded3970902f7b674b3698893e538b69284

Early rebound before week 20 occurred in 8 arm A and 30 arm B participants: 75% versus 11% (P < 0.001). The median time to ART restart was 45.4 weeks in arm A ... compared with 4.6 weeks in arm B ... (P < 0.001).